Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > L Camille Bedrosian > Profile

L Camille Bedrosian

Affiliations

  • Chief Medical Officer at Amylyx Pharmaceuticals Inc. (AMLX), 2024-12-03
  • Director at Rhythm Pharmaceuticals Inc. (RYTM), 2024-06-25
  • at Crinetics Pharmaceuticals Inc. (CRNX), 2024-06-11
  • Evp And Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), 2023-03-04
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Amylyx Pharmaceuticals Inc.
 AMLX $5.54 5,421 138,380 2024-12-02 Filing
Amylyx Pharmaceuticals Inc.
 AMLX $3.20 11,442 143,801 2024-09-30 Filing
Ultragenyx Pharmaceutical Inc.
 RARE $45.25 3,881 Officer 46,720 2023-03-01 Filing
Ultragenyx Pharmaceutical Inc.
 RARE $66.62 2,821 Officer 33,938 2022-03-01 Filing
Ultragenyx Pharmaceutical Inc.
 RARE $66.30 1,657 Officer 36,759 2022-01-30 Filing